Exact Mass: 275.048
Exact Mass Matches: 275.048
Found 75 metabolites which its exact mass value is equals to given mass value 275.048,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Paraoxon
Paraoxon is an acetylcholinesterase inhibitor. It is an organophosphate oxon, and the active metabolite of the insecticide parathion. It is also used as an opthamological drug against glaucoma. Paraoxon is one of the most potent acetylcholinesterase-inhibiting insecticides available, around 70\\% as potent as the nerve agent sarin, and so is now rarely used as an insecticide due to the risk of poisoning to humans and other animals. It is easily absorbed through skin, and was used as an assassination weapon by the apartheid-era South African chemical weapons program Project Coast. [HMDB] Paraoxon is an acetylcholinesterase inhibitor. It is an organophosphate oxon, and the active metabolite of the insecticide parathion. It is also used as an opthamological drug against glaucoma. Paraoxon is one of the most potent acetylcholinesterase-inhibiting insecticides available, around 70\\% as potent as the nerve agent sarin, and so is now rarely used as an insecticide due to the risk of poisoning to humans and other animals. It is easily absorbed through skin, and was used as an assassination weapon by the apartheid-era South African chemical weapons program Project Coast. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EB - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
D-glucosaminic acid 6-phosphate
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)
Nifuroxazide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents
PARAOXON
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EB - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors An aryl dialkyl phosphate where both the alkyl groups are ethyl and the aryl group is 4-nitrophenyl. C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
(R)-2-(2-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(R)-2-(3-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
Benzenecarbohydrazonoylchloride, N-(4-nitrophenyl)-
4-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
3-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
7-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
6-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
8-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
4-(4-chlorophenyl)piperidine-4-carboxylic acid,hydrochloride
4-BENZYL-2-MORPHOLINECARBONYL CHLORIDE HYDROCHLORIDE
Benzaldehyde,4-[bis(2-chloroethyl)amino]-2-methoxy-
(S)-2-(3-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
2-(2-CHLORO-ACETYLAMINO)-4,5-DIMETHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
ETHYL1-(3-CHLOROPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLATE
1-(2-CHLORO-PHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLICACIDETHYLESTER
ETHYL1-(4-CHLOROPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLATE
(S)-2-(2-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
N-(4-Chloro-3-cyano-7-methoxy-6-quinolinyl)acetamide
Ethyl 5-chloropyrazolo[1,5-a]quinazoline-3-carboxylate
3-(CHLOROMETHYL)-5-(5-METHYL-3-PHENYLISOXAZOL-4-YL)-1,2,4-OXADIAZOLE
N-(4-Chloro-3-cyano-6-methoxy-7-quinolinyl)acetamide
5-FLUORO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINEHYDROCHLORIDE
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile
2-Pyrimidinamine, 4-(4-chloro-6-Methoxy-3H-pyrrolo[2,3-b]pyridin-3-yl)-
(2S,4R)-4-(2-Chlorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride
(2S,4R)-4-(3-Chlorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride
(2S,4R)-4-(4-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(S)-2-(4-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(R)-2-(4-CHLOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
2-(CHLOROMETHYL)-5-(5-METHYL-3-PHENYLISOXAZOL-4-YL)-1,3,4-OXADIAZOLE
N-[[(4-Nitrophenyl)amino]carbonyl]-β-alanine sodium
(4S)-2-[3-(Difluoromethoxy)phenyl]-1,3-thiazolidine-4-carboxylic acid
4,5-Dimethoxy-2-[(methylsulfonyl)amino]benzoic acid
4-Amino-N-[(2-Sulfanylethyl)carbamoyl]benzenesulfonamide
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)
[4-[(2S)-2-azaniumyl-3-methoxy-3-oxopropyl]phenyl] sulfate
N,N-Bis(2-chloroethyl)-p-aminophenylacetic acid
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
